Pascal Koenig
Co-Founder, AVA
After graduating from the University of St. Gallen and Columbia Business School, Mr. Pascal Koenig started his career at McKinsey & Company. In the last 15 years, he has worked at the interface of wearable technologies and healthcare. Before co-founding Ava, he built up Limmex, a watch-based emergency system for seniors, and Cardiosafe, a real-time alarming system for cardiac patients.
Mr. Koenig’s latest start-up is AVA, a digital health company with offices in Zurich, San Francisco, Belgrade, Manila and Hong Kong. The company aims to advance women’s reproductive health by bringing together artificial intelligence and clinical research. Its fertility tracking sensor bracelet detects the five most fertile days of a woman’s cycle in real time, while also delivering personalized insight about reproductive health and pregnancy. Worn only during sleep, the Ava bracelet tracks multiple physiological parameters, including pulse rate, breathing rate, and temperature. The company’s first product was launched in the USA in July 2016 and is now sold in 36 countries. The company is backed by USD 40m of venture financing. Mr. Koenig has won various international prizes, and Ava was honored “Best Swiss Startup” in 2017 and 2018.
After graduating from the University of St. Gallen and Columbia Business School, Mr. Pascal Koenig started his career at McKinsey & Company. In the last 15 years, he has worked at the interface of wearable technologies and healthcare. Before co-founding Ava, he built up Limmex, a watch-based emergency system for seniors, and Cardiosafe, a real-time alarming system for cardiac patients.
Mr. Koenig’s latest start-up is AVA, a digital health company with offices in Zurich, San Francisco, Belgrade, Manila and Hong Kong. The company aims to advance women’s reproductive health by bringing together artificial intelligence and clinical research. Its fertility tracking sensor bracelet detects the five most fertile days of a woman’s cycle in real time, while also delivering personalized insight about reproductive health and pregnancy. Worn only during sleep, the Ava bracelet tracks multiple physiological parameters, including pulse rate, breathing rate, and temperature. The company’s first product was launched in the USA in July 2016 and is now sold in 36 countries. The company is backed by USD 40m of venture financing. Mr. Koenig has won various international prizes, and Ava was honored “Best Swiss Startup” in 2017 and 2018.
